Assignee
VISUS THERAPEUTICS INC
US·1 granted patent·8 pending applications·0 citations·filing 2020–2025
Top patents by PatentIndex Score
9 records- 0175US12268662B2Formulations comprising carbachol and brimonidine to enhance anti- presbyopia effectsVISUS THERAPEUTICS INC·Filed 2023·Granted Apr 8, 2025·0 cites·11 claims
- 0273US2023277620A1Histatin for corneal wound healing and ocular surface diseaseVISUS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0369US2024100046A1Degradant compound in a medicamentVISUS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0460US2023390284A1Degradant compound in a medicantVISUS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0557US2026000634A1Carbachol formulations to enhance anti-presbyopia effectsVISUS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0656US2023210821A1Using parasympathomimetic drugs alone or, in combination with one or more alpha agonists in pseudophakic patients, to create multi-focalityVISUS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0756US2025276038A1Histatin combinations and methods for treating or inhibiting cell lossVISUS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0846US2022175734A1Using parasympathomimetic drugs alone or, in combination with one or more alpha agonists in pseudophakic patients, to create multi-focalityVISUS THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0946US2022257593A1Carabachol-bromonidine formulation to enhance anti-presbyopia effectsVISUS THERAPEUTICS INC·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →